See more : AstraZeneca PLC (ZEG.DE) Income Statement Analysis – Financial Results
Complete financial analysis of NorthView Acquisition Corporation (NVACW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NorthView Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- Shaanxi Broadcast & TV Network Intermediary(Group)Co.,Ltd. (600831.SS) Income Statement Analysis – Financial Results
- Southern Urals Nickel Plant PJSC (UNKL.ME) Income Statement Analysis – Financial Results
- Zimplats Holdings Limited (ZMPLF) Income Statement Analysis – Financial Results
- Companhia Energética do Rio Grande do Norte – COSERN (CSRN5.SA) Income Statement Analysis – Financial Results
- Energizer Holdings, Inc. (ENR) Income Statement Analysis – Financial Results
NorthView Acquisition Corporation (NVACW)
About NorthView Acquisition Corporation
NorthView Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus its search on target businesses in the healthcare sector. The company was incorporated 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.51M | 1.27M | 0.00 |
| Gross Profit | -1.51M | -1.27M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.27M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 1.51M | 1.27M | 45.05K |
| Other Expenses | 0.00 | 0.00 | -45.05K |
| Operating Expenses | 0.00 | 1.27M | 45.05K |
| Cost & Expenses | 1.51M | 1.27M | 45.05K |
| Interest Income | 2.25M | 2.58M | 9.69K |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.51M | 1.27M | 67.57K |
| EBITDA | 3.13M | 7.67M | 300.43K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.51M | -1.27M | -45.05K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.13M | 8.94M | 345.48K |
| Income Before Tax | 1.62M | 7.67M | 300.43K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 456.79K | 499.21K | -345.48K |
| Net Income | 1.16M | 7.17M | 300.43K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | 0.19 | 0.30 | 0.01 |
| EPS Diluted | 0.19 | 0.30 | 0.01 |
| Weighted Avg Shares Out | 6.10M | 24.17M | 24.17M |
| Weighted Avg Shares Out (Dil) | 6.10M | 24.17M | 24.17M |
Source: https://incomestatements.info
Category: Stock Reports